AI assistant
Sending…
Protagonist Therapeutics, Inc — Director's Dealing 2019
May 17, 2019
31163_dirs_2019-05-16_0c865536-01cb-4809-9e2a-569e323c20b1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Protagonist Therapeutics, Inc (PTGX)
CIK: 0001377121
Period of Report: 2019-05-15
Reporting Person: Saks Samuel R (Chief Medical Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-05-15 | Stock Option (right to buy) | $10.80 | A | 45000 | Acquired | 2029-05-14 | Common Stock (45000) | Direct |
Footnotes
F1: The stock option vests in 48 equal monthly installments following the date of grant.
More from Protagonist Therapeutics, Inc
Interim / Quarterly Report
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 28
Director's Dealing
2026
Mar 28
Director's Dealing
2026
Mar 28
Director's Dealing
2026
Mar 28
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Mar 26
Regulatory Filings
2026
Mar 24
Annual Report
2026
Feb 25